Astec LifeSciences Limited — Results, 27-04-2026: Financial Results Updates

Astec LifeSciences' Board has approved its audited financial results for the quarter and financial year ended March 31, 2026 (standalone and consolidated), noting an unmodified opinion from statutory auditors. The company has announced its 32nd Annual General Meeting on July 31, 2026, with book closure from July 26 to July 30. Additionally, the Board will seek shareholder approval via postal ballot for several key appointments, including Mr. Vishal Sharma, Mr. Burjis N. Godrej, Mr. Arijit Mukherjee (as Executive Director & COO), and Mr. Mathew Eipe (as Independent Director), along with material related party transactions for FY27. This outlines crucial governance and financial updates.